✦ LIBER ✦

High rate of early posttreatment relapse in chronic hepatitis B (CHB) patients (PTS) with HBeAg seroconversion after lamivudine treatment

✍ Scribed by O.S. Kwon; K.S. Byun; J.H. Kim; J.S. Kim; Y.T. Bak; J.E. Yeon; C.H. Lee

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

712 VIROLOGICAL RELAPSE RATE AFTER TREAT

✍ M. Gill; U. Adeeb; S. Naseem 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Natural history of extended lamivudine (

✍ Nicholas Tassopoulos; George Anagnostopoulos; Vana Sypsa; Johanna Delladetsima; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 112 KB

Efficacy of lamivudine re-treatment for

✍ J. W. Shin; N. H. Park; J. H. Park; J. H. Park; I. D. Jeong; S-J. Bang; K. R. Jo 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

706 SUSTAINED DURABILITY OF HBEAG SEROCO

✍ T. Poynard; J.-L. Hou; A. Chutaputti; M. Manns; N. Naoumov 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Long-term effect of lamivudine treatment

✍ S.P. Hong; K.-H. Han; S.H. Ahn; Y.H. Paik; K.S. Lee; C.Y. Chon; Y.M. Moon 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Extended lamivudine treatment in patient

✍ Nancy W.Y. Leung; Ching-Lung Lai; Ting-Tsung Chang; Richard Guan; Chuan-Mo Lee; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB